Rua Bioscience Limited (NZE: RUA)
New Zealand
· Delayed Price · Currency is NZD 0.0280
0.00 (0.00%)
Jan 7, 2025, 1:38 PM NZST
Rua Bioscience Cash Flow Statement
Financials in millions NZD. Fiscal year is July - June.
Millions NZD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
| Net Income | -13.72 | -13.72 | -5.96 | -8.64 | -4.42 | -2.81 | Upgrade
|
| Depreciation & Amortization | 0.4 | 0.4 | 0.68 | 0.81 | 0.69 | 0.21 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | 0.01 | -0 | 0 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 9.21 | 9.21 | 5.57 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.37 | 0.37 | 0.09 | -0.14 | 0.54 | 0.4 | Upgrade
|
| Other Operating Activities | -0.11 | -0.11 | -6 | 1.07 | -1.84 | -0.8 | Upgrade
|
| Change in Accounts Receivable | 0.59 | 0.59 | -0.29 | 0.1 | 0.37 | -0.71 | Upgrade
|
| Change in Inventory | -0.26 | -0.26 | 0.15 | -0.24 | - | - | Upgrade
|
| Change in Accounts Payable | 0.03 | 0.03 | 0.09 | 0 | 0.26 | 0.05 | Upgrade
|
| Change in Unearned Revenue | 0.06 | 0.06 | 0 | 0.01 | -0.09 | 0.09 | Upgrade
|
| Change in Other Net Operating Assets | -0.31 | -0.31 | -0.28 | 0.17 | 0.04 | -0.06 | Upgrade
|
| Operating Cash Flow | -3.74 | -3.74 | -5.92 | -6.84 | -4.45 | -3.63 | Upgrade
|
| Capital Expenditures | -0 | -0 | -0.07 | -0.4 | -1.4 | -5.02 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.05 | 0.03 | 0 | 0.02 | 0 | Upgrade
|
| Cash Acquisitions | - | - | - | 0.88 | - | - | Upgrade
|
| Investment in Securities | 2 | 2 | 6 | 5 | -13.12 | 2 | Upgrade
|
| Other Investing Activities | 0.16 | 0.16 | 0.71 | 0.11 | 0.07 | 0.05 | Upgrade
|
| Investing Cash Flow | 2.21 | 2.21 | 6.67 | 5.59 | -14.43 | -2.97 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.04 | Upgrade
|
| Long-Term Debt Repaid | -0.08 | -0.08 | -0.1 | -0.16 | -0.16 | -0.11 | Upgrade
|
| Net Debt Issued (Repaid) | -0.08 | -0.08 | -0.1 | -0.16 | -0.16 | -0.06 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 20 | 7 | Upgrade
|
| Other Financing Activities | -0.02 | -0.02 | -0.02 | -0.04 | -1.54 | -0.57 | Upgrade
|
| Financing Cash Flow | -0.09 | -0.09 | -0.12 | -0.21 | 18.3 | 6.36 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | -0.01 | - | - | - | - | Upgrade
|
| Net Cash Flow | -1.63 | -1.63 | 0.63 | -1.46 | -0.58 | -0.24 | Upgrade
|
| Free Cash Flow | -3.74 | -3.74 | -5.99 | -7.25 | -5.85 | -8.65 | Upgrade
|
| Free Cash Flow Margin | -1181.50% | -1181.50% | -896.65% | -1123.09% | -1627.85% | - | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.04 | -0.05 | -0.05 | -0.09 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | Upgrade
|
| Levered Free Cash Flow | -2.9 | -2.9 | -6.93 | -1.53 | -3.71 | -7.27 | Upgrade
|
| Unlevered Free Cash Flow | -2.89 | -2.89 | -6.92 | -1.5 | -3.69 | -7.26 | Upgrade
|
| Change in Net Working Capital | 0.77 | 0.77 | 3.6 | -2.96 | -0.35 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.